Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 3
1982 5
1983 5
1984 11
1985 11
1986 16
1987 13
1988 16
1989 28
1990 28
1991 22
1992 35
1993 81
1994 195
1995 270
1996 305
1997 297
1998 336
1999 302
2000 306
2001 312
2002 297
2003 304
2004 299
2005 280
2006 284
2007 289
2008 363
2009 357
2010 404
2011 479
2012 547
2013 541
2014 534
2015 498
2016 511
2017 460
2018 438
2019 286
2020 18
Text availability
Article attribute
Article type
Publication date

Search Results

8,943 results
Results by year
Filters applied: . Clear all
Page 1
Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.
Malehmir M, Pfister D, Gallage S, Szydlowska M, Inverso D, Kotsiliti E, Leone V, Peiseler M, Surewaard BGJ, Rath D, Ali A, Wolf MJ, Drescher H, Healy ME, Dauch D, Kroy D, Krenkel O, Kohlhepp M, Engleitner T, Olkus A, Sijmonsma T, Volz J, Deppermann C, Stegner D, Helbling P, Nombela-Arrieta C, Rafiei A, Hinterleitner M, Rall M, Baku F, Borst O, Wilson CL, Leslie J, O'Connor T, Weston CJ, Adams DH, Sheriff L, Teijeiro A, Prinz M, Bogeska R, Anstee N, Bongers MN, Notohamiprodjo M, Geisler T, Withers DJ, Ware J, Mann DA, Augustin HG, Vegiopoulos A, Milsom MD, Rose AJ, Lalor PF, Llovet JM, Pinyol R, Tacke F, Rad R, Matter M, Djouder N, Kubes P, Knolle PA, Unger K, Zender L, Nieswandt B, Gawaz M, Weber A, Heikenwalder M. Malehmir M, et al. Nat Med. 2019 Apr;25(4):641-655. doi: 10.1038/s41591-019-0379-5. Epub 2019 Apr 1. Nat Med. 2019. PMID: 30936549 Free article.
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.
Dhar D, Antonucci L, Nakagawa H, Kim JY, Glitzner E, Caruso S, Shalapour S, Yang L, Valasek MA, Lee S, Minnich K, Seki E, Tuckermann J, Sibilia M, Zucman-Rossi J, Karin M. Dhar D, et al. Cancer Cell. 2018 Jun 11;33(6):1061-1077.e6. doi: 10.1016/j.ccell.2018.05.003. Cancer Cell. 2018. PMID: 29894692 Free PMC article.
Molecular mechanisms of lineage decisions in metabolite-specific T cells.
Legoux F, Gilet J, Procopio E, Echasserieau K, Bernardeau K, Lantz O. Legoux F, et al. Nat Immunol. 2019 Sep;20(9):1244-1255. doi: 10.1038/s41590-019-0465-3. Epub 2019 Aug 20. Nat Immunol. 2019. PMID: 31431722
CD44 splice isoform switching determines breast cancer stem cell state.
Zhang H, Brown RL, Wei Y, Zhao P, Liu S, Liu X, Deng Y, Hu X, Zhang J, Gao XD, Kang Y, Mercurio AM, Goel HL, Cheng C. Zhang H, et al. Genes Dev. 2019 Feb 1;33(3-4):166-179. doi: 10.1101/gad.319889.118. Epub 2019 Jan 28. Genes Dev. 2019. PMID: 30692202 Free PMC article.
Aberrant T Cell Signaling and Subsets in Systemic Lupus Erythematosus.
Katsuyama T, Tsokos GC, Moulton VR. Katsuyama T, et al. Front Immunol. 2018 May 17;9:1088. doi: 10.3389/fimmu.2018.01088. eCollection 2018. Front Immunol. 2018. PMID: 29868033 Free PMC article. Review.
Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44.
Shan M, Carrillo J, Yeste A, Gutzeit C, Segura-Garzón D, Walland AC, Pybus M, Grasset EK, Yeiser JR, Matthews DB, van de Veen W, Comerma L, He B, Boonpiyathad T, Lee H, Blanco J, Osborne LC, Siracusa MC, Akdis M, Artis D, Mehandru S, Sampson HA, Berin MC, Chen K, Cerutti A. Shan M, et al. Immunity. 2018 Oct 16;49(4):709-724.e8. doi: 10.1016/j.immuni.2018.08.013. Epub 2018 Oct 2. Immunity. 2018. PMID: 30291028 Free PMC article.
CHML promotes liver cancer metastasis by facilitating Rab14 recycle.
Chen TW, Yin FF, Yuan YM, Guan DX, Zhang E, Zhang FK, Jiang H, Ma N, Wang JJ, Ni QZ, Qiu L, Feng J, Zhang XL, Bao Y, Wang K, Cheng SQ, Wang XF, Wang X, Li JJ, Xie D. Chen TW, et al. Nat Commun. 2019 Jun 7;10(1):2510. doi: 10.1038/s41467-019-10364-0. Nat Commun. 2019. PMID: 31175290 Free PMC article.
8,943 results
Jump to page
Feedback